This recombinant human antibody is a novel monoclonal antibody that binds specifically to delta-like ligand (DLL4). The antibody was purified by affinity chromatography. It can be used for ELISA, FC, Neut and other applications. The antibody inhibits the growth of cancer cells by inhibiting the interaction between DLL4 ligand and Notch. The IC₅₀ value of decreasing human DLL4-His bound to Notch 1-Fc is 1.32 nM.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-204 | Anti-Human DLL4 Recombinant Antibody (TAB-204) | ELISA, FC, IP, FuncS, IF, Neut, WB | IgG2 - kappa |
There are currently no Customer reviews or questions for TAB-218MZ. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.